PATENT CLAIM ANALYSIS

Application Number: 15861492
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "178000"]

Abstract:
Provided oral testosterone undecanoate compositions can be administered to hypogonadal males with a meal without the fat content of the meal substantially effecting bioavailability.

Claim (Index 11):
A method for replacement therapy in a male for conditions associated with a deficiency or absence of endogenous testosterone, said method comprising: orally administering to a male having a condition associated with a deficiency or absence of endogenous testosterone, with a meal having about 10 wt % to 50 wt % fat, a pharmaceutical composition comprising from about 50 mg to about 300 mg of testosterone undecanoate and a pharmaceutically acceptable carrier said pharmaceutical acceptable carrier being selected to provide bioequivalent amounts of serum testosterone, testosterone undecanoate, dihydrotestosterone, or dihydrotestosterone undecanoate levels to said male when administered with meals containing (1) standard fat as compared to low fat and high fat, (2) low fat to high fat, or (3) a combination thereof.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 86.0
- Lexical Diversity: 1.08696
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14952796', '15485154', '14691229', '15818697', '15594508']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7941251831698132
- 35 USC 102 Novelty (BERT): 0.5403681123864728
- Combined Prediction Score: 0.7687494760914791
- Mean Citation Score: 373.482492
- Max Citation Score: 396.47708
- Similarity Product: 301.6118075433278

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test